Launching (and Protecting) Your Ketamine Practice

Sarepta shares PhII data for next-gen exon skipping drug, but regulatory pathway is unclear

Sarepta Therapeutics announced Monday that its experimental Duchenne muscular dystrophy drug led to some expression of dystrophin — the muscle protein that is mutated in

January 30, 2024

Researchers seek answers to racial disparities for prostate and breast cancer among people of African ancestry

For almost 44 years, Willie Bell never missed his appointment to check for prostate cancer. But then the pandemic hit. The doctor’s office was closed.

August 1, 2023

Routine genomic surveillance at antenatal care can be a cost-effective approach to detect changes in malaria transmission

Genetic diversity of the malaria parasite in pregnant women and children declined in an area targeted for malaria elimination in Mozambique, according to a study

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.